HOLM PER has a total of 23 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are MOBERG DERMA AB, BIO & BIO LICENSING SA and M G THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Holm Per | 22 |
#2 | Norling Tomas | 19 |
#3 | Holm Per Sonne | 1 |
#4 | Wagner Sven | 1 |
#5 | Liljegren Ken | 1 |
#6 | Nielsen Ole | 1 |
Publication | Filing date | Title |
---|---|---|
US2007026062A1 | Tablet comprising a fibrate | |
WO2006119779A2 | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution | |
US2008131503A1 | Stable Pharmaceutical Composition Comprising a Fixed Dose Combination of Fenofibrate and an Hmg-Coa Reductase Inhibitor | |
CA2610360A1 | E1-minus adenoviruses and use thereof | |
US2007105912A1 | Pharmaceutical compositions comprising lercanidipine | |
US2006287352A1 | Modified release compositions comprising tacrolimus |